In summary, in the present study we evaluated the potential roles of miR-149-5p and PAFR signaling in relation to lung cancer growth and the cytotoxic response of targeted therapy, and found that miR-149 overcame PAFR activation-induced increased cell proliferation, and PAFR activation attenuated the cytotoxic response of targeted therapy. This evidence concerns the gene PTAFR and lung cancer.